Today: 20 May 2026
Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next
12 January 2026
1 min read

Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

New York, Jan 12, 2026, 05:30 EST — Premarket

  • PAAS was up about 4.5% in premarket trade, tracking a surge in silver.
  • Silver futures climbed roughly 6% early Monday as investors piled into hard assets.
  • Pan American’s next big scheduled catalyst is its Feb. 18 results, with conferences later this month.

Pan American Silver Corp shares rose 4.5% in U.S. premarket trading on Monday, lifting the stock to $56.70 as precious metals ripped higher.

Silver hit fresh records as investors rushed into “hard” assets after headlines around a criminal probe involving Federal Reserve Chair Jerome Powell and a sharper geopolitical backdrop. “With the Fed’s independence now openly contested,” investors were shifting toward hard assets, said Zain Vawda, an analyst at MarketPulse by OANDA. Reuters

Silver futures were last up about 6% on CME’s Globex session early Monday. That matters for miners because revenue is tied to the metal price, while costs don’t move in lockstep — a setup that can amplify gains and losses in the share price.

Pan American ended the last regular U.S. session on Friday up 2.2% at $54.27, after trading between $53.32 and $54.79, according to Yahoo Finance data.

The move looked sector-wide. Hecla Mining, First Majestic Silver and Coeur Mining were all higher in early indications, and the Global X Silver Miners ETF also rose.

The backdrop is messy. The Powell investigation story has stirred fears about central-bank independence and knocked risk appetite, pushing money toward metals and away from the dollar-linked trade, the Financial Times reported.

For Pan American, investors are now looking past the open and toward scheduled checkpoints. The company is due at the CIBC Western Conference on Jan. 21-23 and TD Cowen’s global mining conference on Jan. 27-29, and it has its fourth-quarter and year-end 2025 financial results set for Feb. 18.

A lot will come down to how much of Monday’s metal move sticks. Silver has a habit of gapping higher, then giving it back when volatility spikes and traders take profit.

There’s also the company-specific risk investors can’t hedge with a futures contract: mining costs, operational hiccups and permitting or tax surprises across the jurisdictions where it operates. If the metal cools while costs stay hot, margins compress fast.

Stock Market Today

  • Okta (OKTA) Stock Declines Amid Market Despite Strong Earnings Outlook
    May 19, 2026, 7:32 PM EDT. Okta (OKTA) shares fell 1.68% to $74.45, underperforming the S&P 500's slight 0.02% decline. The cloud identity management firm is expected to report earnings per share (EPS) of $0.57, a 29.55% increase year-over-year, and revenue of $649.35 million, up 11.19%. Annual forecasts predict EPS of $2.61 and revenue of $2.56 billion, marking increases of 63.13% and 13.19%, respectively. Despite the recent stock drop, Okta holds a Zacks Rank #1 (Strong Buy), reflecting optimistic analyst revisions. The stock trades at a forward price-to-earnings ratio of 29.07, above the industry average of 17.59, and a PEG ratio of 1.26 compared to the industry's 1.58, indicating valuation relative to earnings growth.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L
Previous Story

National Grid plc stock drops today as markets wobble; dividend clock ticks on NG.L

Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open
Next Story

Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open

Go toTop